» Articles » PMID: 31781642

Exosomes May Be the Potential New Direction of Research in Osteoarthritis Management

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2019 Nov 30
PMID 31781642
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoarthritis (OA) is a joint degenerative disease, which is prominent in the middle-aged and elderly population, often leading to repeated pain in the joints of patients and seriously affecting the life quality of patients. At present, the treatment of OA mainly depends on the surgery and drug treatment. Nevertheless, these treatments still face many problems, such as surgical safety, complications, and drug side effects. Exosomes can be secreted and released by multiple cell types and have lipid bilayer membranes and contain abundant biological molecules, including proteins, lipids, and nucleic acids. Moreover, exosomes play a critical role in local and distal intercellular and intracellular communication. In recent years, several studies have found that exosomes can regulate the progression of OA and have a potential efficacy for OA treatment. Thus, in this article, we summarize and review the relevant research of exosomes in OA and emphasize the importance of exosomes in the development of OA.

Citing Articles

Mesenchymal stem cell-derived extracellular vesicles for cell-free therapy of ocular diseases.

Liu X, Hu L, Liu F Extracell Vesicles Circ Nucl Acids. 2024; 3(2):102-117.

PMID: 39698446 PMC: 11648472. DOI: 10.20517/evcna.2022.08.


Removing the stumbling block of exosome applications in clinical and translational medicine: expand production and improve accuracy.

Han L, Zhao Z, He C, Li J, Li X, Lu M Stem Cell Res Ther. 2023; 14(1):57.

PMID: 37005658 PMC: 10068172. DOI: 10.1186/s13287-023-03288-6.


The Involvement of Neutrophils in the Pathophysiology and Treatment of Osteoarthritis.

Chaney S, Vergara R, Qiryaqoz Z, Suggs K, Akkouch A Biomedicines. 2022; 10(7).

PMID: 35884909 PMC: 9313259. DOI: 10.3390/biomedicines10071604.


Associations between serum biomarkers of cartilage metabolism and serum hyaluronic acid, with risk factors, pain categories, and disease severity in knee osteoarthritis: a pilot study.

Papaneophytou C, Alabajos-Cea A, Viosca-Herrero E, Calvis C, Costa M, Christodoulides A BMC Musculoskelet Disord. 2022; 23(1):195.

PMID: 35236298 PMC: 8889762. DOI: 10.1186/s12891-022-05133-y.


Harnessing Tissue-derived Extracellular Vesicles for Osteoarthritis Theranostics.

Yin B, Ni J, Witherel C, Yang M, Burdick J, Wen C Theranostics. 2022; 12(1):207-231.

PMID: 34987642 PMC: 8690930. DOI: 10.7150/thno.62708.


References
1.
Jiang S, Lu J, Deng Z, Li Y, Lei G . Long noncoding RNAs in osteoarthritis. Joint Bone Spine. 2016; 84(5):553-556. DOI: 10.1016/j.jbspin.2016.09.006. View

2.
Price J, Waters J, Darrah C, Pennington C, Edwards D, Donell S . The role of chondrocyte senescence in osteoarthritis. Aging Cell. 2003; 1(1):57-65. DOI: 10.1046/j.1474-9728.2002.00008.x. View

3.
Zorzopulos J, Opal S, Hernando-Insua A, Rodriguez J, Elias F, Flo J . Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy. World J Stem Cells. 2017; 9(3):45-67. PMC: 5368622. DOI: 10.4252/wjsc.v9.i3.45. View

4.
Glyn-Jones S, Palmer A, Agricola R, Price A, Vincent T, Weinans H . Osteoarthritis. Lancet. 2015; 386(9991):376-87. DOI: 10.1016/S0140-6736(14)60802-3. View

5.
Kato T, Miyaki S, Ishitobi H, Nakamura Y, Nakasa T, Lotz M . Exosomes from IL-1β stimulated synovial fibroblasts induce osteoarthritic changes in articular chondrocytes. Arthritis Res Ther. 2014; 16(4):R163. PMC: 4261911. DOI: 10.1186/ar4679. View